Sutherland Health signs distribution deal with Lansinoh Laboratories Inc.

                                                                                                                                                                                  9 September 2013
SUTHERLAND HEALTH GROUP PLC
("Sutherland Health Group" or "the Company")
ISDX Symbol: SHGP
 
Distribution Agreement signed with Lansinoh Laboratories Inc.
 
The Board of Sutherland Health Group, a national supplier of personal care, patient hygiene,sexual health and gynaecology products to customers including the National Health Service ("NHS"), is pleased to announce that it has signed a distribution agreement with Lansinoh Laboratories Inc. to supply the Lansinoh® range of breastfeeding products to the National Health Service (NHS); Private Hospitals; GP Consortiums; Charities and selected Medical wholesalers in the UK.
 
Lansinoh® Breast Pumps; Disposable Nursing Pads and Nipple Cream for breastfeeding mums are already successfully sold in retail stores in the UK and will now be distributed by Sutherland Health Group into a UK medical market that has seen a rise in the number of annual births in recent years to in excess of 800,000 births per annum.
 
Vanessa Cook Managing Director for Lansinoh Laboratories EMEA commented: “We are delighted that we have signed this important distribution agreement with Sutherland Health Group an already recognised and important supplier to the medical and NHS markets in the UK. We look forward to a long and successful relationship with them enabling us to work even closer with UK health professionals and to reach more new mothers”
 
Chairman John French commented: “We are pleased to have signed an agreement with one of the world’s leading manufacturers of breastfeeding products and believe this fits very well with our strategy of becoming a leading supplier of quality brands and products to the NHS and medical markets and is also further evidence of our ability in bringing our own and distributed products to the UK medical market. We hope to be able inform shareholders of other new developments during the course of the financial year.”
 
The Directors of the Issuer accept responsibility for this announcement.
 
For further information:
 
John French, Chairman
Sutherland Health Group plc
E: john@sutherlandhealth.com
T: 07836 722 482
 
Ross Andrews
Andrew Jones
Zeus Capital Ltd
T: 0161 831 1512
 
Notes to Editors:
 
Sutherland Health Group Plc is a national supplier of personal care; patient hygiene, sexualhealth and diagnostic products to the UK National Health Service (NHS) andother UK customers. Its aim is to supply innovative solutions to current healthissues by studying current trends and working alongside leading professionalswho also work within the health sector.
 
The company is committed to developing and marketing high quality brands and products that will benefit health professionals and consumers alike in manyareas of health. The Group has established its own brands: Condomania® Condoms;Sutherland® Patient Hygiene and Personal Care; Lubricating Jelly; and Vision®pregnancy and gynaecology diagnostics. These products have already becomeestablished within the NHS business.
 
The Group is ISO and MHRA registered, and at present principally manufactures and operates within the United Kingdom.
 
For further information on the Company visit www.sutherlandhealth.com 
 

Latest news RSS

09/11/2017

Sutherland at Procurex Wales 2017

Sutherland at Procurex Wales 2017

29/06/2017

Final Results 30th September 2016

Sutherland Health Group Final Results September 2016

11/11/2016

Sutherland Attending European Midwives Conference

Sutherland Attending EMA Conference

Sign up

Subscribe

For further information, please read our Privacy Policy.